CNBC Television published this video item, entitled “Moderna’s mRNA RSV vaccine propels stock gains” – below is their description.
Michael Yee, managing director at Jefferies, joins ‘The Exchange’ to discuss what’s driving Moderna’s stock activity, the unique mRNA technology behind the company’s RSV vaccine and portfolio opportunities in the biotech business.
CNBC Television YouTube Channel
Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.